经 深圳监管局 查实， 英集芯 脑机接口产品的技术路径为非侵入式，与国外侵入式主导技术路径存在显著差异。 且"IPA1299 芯片"为英 集芯与参股公司精芯唯尔(常州)电子科技有限公司共同推出，目前处于市场培育期，尚未形成规模化销售及收入，与回复中所称的"公司推 出的 IPA1299""已量产出货"描述不符。 因蹭"脑机接口"热点， 英集芯（ 688209.SH）和亚辉龙（ 688575.SH）同日 遭到处罚，金额合计1550万元。 3月17日晚间， 英集芯 发布公告称，公司于 当 日收到中国证监会深圳监管局下发的《行政处罚事先告知书》 （《 告知书 》） ，因涉嫌 信息披露违法违规，公司及三名核心高管拟被合计罚款800万元 。 其中 ， 英集芯 被罚400万元，董事兼首席执行官陈鑫、董事长兼总经理黄洪伟、董事会秘书吴任超分别被罚210万元、110万元、80万 元。 英集 此次被罚的核心原因， 主要是因为其在 互动平台自问自答"蹭 "脑机接口 "热点 。 据披露，今年 1月5日，英集芯人为策划以"自问 自答"方式，在上海证券交易所e互动平台发布"公司在脑电信号采集等核心芯片方面的产品进展与后续规划"的提问，并 ...

记者丨 李山 编辑丨张颖国 2026年3月17日晚间，资本市场迎来一波监管密集行动。科创信息（300730）、亚辉龙 （688575）两家公司同步收到正式《行政处罚决定书》，英集芯（688209）、行云科技 （300209）、*ST星农（603789）三家公司及相关主体则领到了《行政处罚事先告知书》。五 家公司同日被罚，合计罚没金额超过3000万元，涉及财务造假、误导性陈述、信披违规等多种 违规类型，监管层"零容忍"的态度清晰可见。 对于上述公司合计近10万投资者而言，罚单落地往往意味着民事索赔的窗口正式打开，行政处 罚的终结恰是维权行动的起点。 符合索赔条件的受损股民可关注"投资快报"公众号，通过右 侧"股民索赔"菜单栏挽回损失。 蹭热点栽跟头，"脑机接口"概念股现形记 在此次被罚的公司中，亚辉龙和英集芯的违规手法颇为相似，两家公司都不约而同地盯上了当 时炙手可热的"脑机接口"概念。 2026年1月6日，亚辉龙高调宣布与"脑机星链"达成战略合作，在公告中描绘了一幅颇为超前的 技术蓝图，宣称合作方拥有"非侵入式与侵入式双技术路径"，并列出脑电采集分析仪、迷走神 经刺激仪等一系列产品名单。然而监管调查发现，这家 ...

Group 1 - The Chinese government has launched a new batch of 13 major foreign investment projects with a planned investment of $13.4 billion, focusing on manufacturing sectors such as electronics, chemicals, automotive, and machinery [2] - The new projects include logistics and biopharmaceutical R&D centers, signaling increased support for the service industry and the integration of modern services with advanced manufacturing [2] - The investment sources are diversified, including multinational companies from the UK, Germany, Switzerland, Sweden, and Turkey [2] Group 2 - The China Securities Regulatory Commission has approved a new batch of 15 hard technology-themed fund products, focusing on core technology and strategic emerging industries [3] - These funds will track indices related to artificial intelligence and China's strategic emerging industries, with plans to start fundraising soon [3] Group 3 - Nvidia's CEO announced at the GTC conference that the AI inference market has reached a turning point, with exponential growth in demand for inference computing power [4] - Nvidia plans to collaborate with a startup focused on inference technology to launch AI server systems, targeting the trillion-level computing market [4] - Huawei introduced new AI data infrastructure aimed at enhancing AI inference efficiency and reducing deployment barriers, with significant improvements in accuracy and utilization rates [4] Group 4 - Tencent Music's stock dropped by 24.65% after reporting a gross margin of 44.7%, below market expectations of 45.1%, and lower-than-expected active user numbers [7] - The company reported total revenue of 8.64 billion yuan for the fourth quarter, a year-on-year increase of 15.9% [7] Group 5 - The U.S. stock market saw slight gains, with the S&P 500 up 0.25%, the Nasdaq up 0.47%, and the Dow Jones up 0.10% [5] - Major tech stocks showed mixed performance, with Tesla, Amazon, and Google all rising, while Nvidia and other tech stocks experienced declines [6]

Core Viewpoint - The article discusses the recent downturn in the A-share market, highlighting the unexpected declines despite initial optimism surrounding events like the GTC conference and the performance of various sectors, particularly real estate and technology [1][5][9]. Market Performance - From March 2 to March 17, the number of declining stocks in the A-share market fluctuated significantly, with peaks of over 4,800 stocks on March 3 and 4,523 on March 17, indicating a bearish trend [4]. - On March 17, the three major indices closed down, with the Shanghai Composite Index falling by 0.85%, the Shenzhen Component by 1.87%, and the ChiNext by 2.29%. The total market turnover was 22,247.26 billion yuan, a decrease of 1,153.86 billion yuan from the previous day [16]. Sector Analysis - The real estate sector has seen mixed signals, with some stocks initially rising but ultimately facing pressure due to broader market trends. The article notes that new housing sales are weak, while second-hand housing remains stable, indicating a lack of strength in the overall market [10]. - The technology sector, particularly stocks related to computing power hardware, experienced significant declines following the GTC conference, with companies like Tianfu Communication and Longguang Huaxin dropping over 10% [16]. Investment Sentiment - There is a prevailing sentiment of caution among investors, with many opting to reduce exposure amid geopolitical tensions and market volatility. The article suggests that controlling positions and adopting a wait-and-see approach may be prudent in the current environment [13][16]. - The article also highlights the potential for foreign capital inflows into Hong Kong, driven by geopolitical factors, as some investors consider reallocating assets due to instability in the Middle East [12][11]. Price Adjustments - Several companies have announced price increases for their products due to rising raw material costs, with Li Min Co. raising prices by 10%-15% for certain pesticides and chemicals, and Murata announcing price hikes of 15%-35% for passive components [21][23]. - The price of Vitamin A has surged by 35% since the end of February, reflecting broader inflationary pressures in the agricultural and chemical sectors [21]. Regulatory Environment - Recent regulatory changes in China have tightened the IPO process for red-chip companies in Hong Kong, which may increase listing costs and affect foreign investment dynamics [13].

记者丨曾静娇 崔文静 编辑丨黎雨桐 3月17日晚间，亚辉龙(688575.SH)公告称，公司于2026年3月17日收到深圳证监局下发的《行政处罚决定 书》。因公司在2026年1月6日发布的关于与脑机星链签订战略合作框架协议的公告中，披露信息不准确、 不完整，涉及技术路线及产品情况，构成误导性陈述，被责令改正、警告并罚款400万元；董事长胡鹍辉被 警告并罚款200万元；董事会秘书王鸣阳被警告并罚款150万元。（注：合计被罚750万元。）公司表示本次 处罚未触及退市情形，目前经营正常。 同日，亚辉龙发布公告，王鸣阳因个人原因，申请辞去董事会秘书职务。辞职后，王鸣阳将继续在公司担任 其他职务。 2026年1月初，脑机接口概念炙手可热。彼时亚辉龙发布公告，宣布与"深圳脑机星链科技有限公司"签订战 略合作协议，声称对方拥有"双技术路径"，且有产品问世。 然而，监管的调查揭示了真相：这家合作伙伴实际上仅有一款产品有样机，所谓的"订单"不过是框架协议。 从首次公告到补充公告，再到问询回复，亚辉龙连续三次信息披露不准确、不完整，构成了误导性陈述。 业绩方面，亚辉龙发布的2025年年度业绩快报显示，公司实现营业收入18.09亿 ...

一、提前离任的基本情况 二、离任对公司的影响 证券代码：688575 证券简称：亚辉龙 公告编号：2026-011 深圳市亚辉龙生物科技股份有限公司 关于董事会秘书辞任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 深圳市亚辉龙生物科技股份有限公司（以下简称"公司"）于近日收到董事 会秘书王鸣阳先生提交的辞职报告，王鸣阳先生因个人原因申请辞去董事会秘书 职务。王鸣阳先生的辞职报告自送达公司董事会之日起生效，其辞职不会对公司 的正常经营活动产生影响，辞职后，王鸣阳先生将继续在公司担任其他职务。在 公司聘任新的董事会秘书之前，暂由公司董事长胡鹍辉先生代为履行董事会秘书 职责。 | | 离任 | | 原定任期 | 离任原 | 是否继 续在上 市公司 | 具体职 | 是否 存在 未履 | | --- | --- | --- | --- | --- | --- | --- | --- | | 姓名 | 职务 | 离任时间 | 到期日 | 因 | 及其控 | 务（如适 | 行完 | | | | | | | 股子公 ...

证券代码：688575 证券简称：亚辉龙 公告编号：2026-010 深圳市亚辉龙生物科技股份有限公司 关于收到行政处罚决定书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 深圳市亚辉龙生物科技股份有限公司（以下简称"公司"）于 2026 年 2 月 6 日收到中国证券监督管理委员会（以下简称"中国证监会"）下发的《立案告 知书》（编号：证监立案字 00720262 号），因涉嫌信息披露违法违规，根据《中 华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会 决定对公司予以立案。公司于 2026 年 2 月 28 日收到中国证监会深圳监管局下发 的《行政处罚事先告知书》（[2026]4 号）。公司于 2026 年 3 月 17 日收到中国 证监会深圳监管局下发的《行政处罚决定书》（[2026]1 号），现将相关情况公 告如下： 一、《行政处罚决定书》的主要内容 "当事人：深圳市亚辉龙生物科技股份有限公司（以下简称亚辉龙或公司）， 住所：广东省深圳市龙岗区宝龙街道宝龙二路亚辉龙生物科技厂区 1 栋。 ...

Core Viewpoint - The A-share market is experiencing a regulatory crackdown on companies attempting to exploit popular trends, leading to significant penalties and investor compensation claims [1] Group 1: Regulatory Actions - The Chairman of the China Securities Regulatory Commission (CSRC), Wu Qing, emphasized the need for strict investigations and penalties against companies engaging in misleading practices that harm investor interests [1] - The rapid initiation of investigations and swift penalties reflect the regulatory body's commitment to maintaining market fairness [1] Group 2: Case Studies - **Yahui Long (688575)**: The company misled investors by announcing a partnership with Shenzhen Brain Machine Starlink Technology Co., claiming it had multiple product paths. Investigations revealed that the partner only had one prototype and the agreements were misleading. The company faces a potential fine of 7.5 million yuan [2] - **Shuangliang Energy (600481)**: The company falsely claimed to have secured a significant order related to SpaceX, which was later revealed to be only 1.392 million yuan, representing just 0.11% of its revenue. The stock was investigated for inaccurate disclosures [4] - **Yingjixin (688209)**: The company engaged in misleading self-promotion on an interactive platform, claiming its chips were mass-produced and comparable to leading products. Subsequent investigations found that the chips were still in the market cultivation phase and not yet commercially viable [6][7]

Core Viewpoint - Shenzhen Yahui Long Biotechnology (688575) is facing administrative penalties from the Shenzhen Securities Regulatory Bureau for misleading disclosures regarding a strategic cooperation agreement, which led to significant stock price fluctuations [1][5]. Group 1: Administrative Penalties - On February 28, 2026, the company received a notice of administrative penalties, indicating that it is suspected of violating information disclosure regulations [2]. - The penalties include a warning and a fine of 4 million yuan for the company, 2 million yuan for Chairman Hu Kunhui, and 1.5 million yuan for Secretary Wang Mingyang, totaling 7.5 million yuan [1][6]. Group 2: Disclosure Violations - The company inaccurately disclosed information about its strategic cooperation with Shenzhen Brain Machine Star Chain Technology Co., Ltd., particularly regarding the development status of products [3][4]. - The initial announcement and subsequent supplementary disclosures failed to accurately reflect the actual development stages of the products, which could mislead investors [5][6]. Group 3: Financial Performance - For the fiscal year 2025, the company reported a total revenue of 201,162.03 million yuan, a decrease of 10.07% year-on-year [7][8]. - The net profit attributable to the parent company was -92.03 million yuan, marking a significant decline of 30,153.36% compared to the previous year [8].

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 深圳市亚辉龙生物科技股份有限公司（以下简称"公司"）于 2026 年 2 月 6 日收到中国证券监督管理委员会（以下简称"中国证监会"）下发的《立案告 知书》（编号：证监立案字 00720262 号），因涉嫌信息披露违法违规，根据《中 华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会 决定对公司予以立案。具体情况详见公司 2026 年 2 月 7 日披露在上海证券交易 所网站（www.sse.com.cn）的《关于收到中国证券监督管理委员会立案告知书的 公告》（编号：2026-007）。 公司于 2026 年 2 月 28 日收到中国证监会深圳监管局下发的《行政处罚事先 告知书》（[2026]4 号），现将相关情况公告如下： 一、《行政处罚事先告知书》的内容 "深圳市亚辉龙生物科技股份有限公司，胡鹍辉先生、王鸣阳先生： 深圳市亚辉龙生物科技股份有限公司（以下简称亚辉龙或公司）涉嫌信息披 露违法违规一案，已由我局调查完毕，我局依法拟对你们作出行政处罚。现将 ...